Jump to main content
Jump to site search

Issue 5, 2018
Previous Article Next Article

Inhibition of O-GlcNAc transferase (OGT) by peptidic hybrids

Author affiliations

Abstract

O-GlcNAc transferase (OGT) attaches a GlcNAc moiety on specific substrate proteins using UDP-GlcNAc as the sugar donor. This modification can alter protein function by regulating cellular signaling and transcription pathways in response to altered nutrient availability and stress. Specific inhibitors of OGT would be valuable tools for biological studies and lead structures for therapeutics. The existing OGT inhibitors are mainly derived from the sugar donor substrate, but poor cell permeability and off-target effects limit their use. Here, we describe our progress on OGT inhibition based on substrate peptides identified by array screening. Subsequently, bisubstrate inhibitors were prepared by conjugating these peptides to uridine in various ways. In parallel, an in silico fragment screening was conducted to obtain small molecules targeting the UDP binding pocket. After evaluation of the initial hits, one of these small molecules was elaborated into a novel OGT hybrid inhibitor, as the replacement of uridine. The novel compounds inhibit OGT activity with IC50 values in the micromolar range.

Graphical abstract: Inhibition of O-GlcNAc transferase (OGT) by peptidic hybrids

Back to tab navigation

Supplementary files

Publication details

The article was received on 28 Feb 2018, accepted on 14 Apr 2018 and first published on 18 Apr 2018


Article type: Research Article
DOI: 10.1039/C8MD00115D
Citation: Med. Chem. Commun., 2018,9, 883-887
  •   Request permissions

    Inhibition of O-GlcNAc transferase (OGT) by peptidic hybrids

    H. Zhang, T. Tomašič, J. Shi, M. Weiss, R. Ruijtenbeek, M. Anderluh and R. J. Pieters, Med. Chem. Commun., 2018, 9, 883
    DOI: 10.1039/C8MD00115D

Search articles by author

Spotlight

Advertisements